scholarly journals A brief review on DNA vaccines in the era of COVID-19

2021 ◽  
Author(s):  
Maryam Shafaati ◽  
Massoud Saidijam ◽  
Meysam Soleimani ◽  
Fereshte Hazrati ◽  
Rasoul Mirzaei ◽  
...  
Keyword(s):  
Gene Expression ◽  
Clinical Trials ◽  
Plasmid Dna ◽  
Dna Vaccines ◽  
Dna Delivery ◽  
Design Strategies ◽  
Chemical Methods ◽  
Delivery Routes ◽  
Physical And Chemical ◽  
Minicircle Dna

This article provides a brief overview of DNA vaccines. First, the basic DNA vaccine design strategies are described, then specific issues related to the industrial production of DNA vaccines are discussed, including the production and purification of DNA products such as plasmid DNA, minicircle DNA, minimalistic, immunologically defined gene expression (MIDGE) and Doggybone™. The use of adjuvants to enhance the immunogenicity of DNA vaccines is then discussed. In addition, different delivery routes and several physical and chemical methods to increase the efficacy of DNA delivery into cells are explained. Recent preclinical and clinical trials of DNA vaccines for COVID-19 are then summarized. Lastly, the advantages and obstacles of DNA vaccines are discussed.

scholarly journals A Comparison of Plasmid DNA and mRNA as Vaccine Technologies

Vaccines ◽  
2019 ◽  
Vol 7 (2) ◽  
pp. 37 ◽  
Author(s):  
Liu
Keyword(s):  
Clinical Trials ◽  
Dna Vaccine ◽  
Plasmid Dna ◽  
Dna Vaccines ◽  
Delivery Systems ◽  
Potential Toxicity ◽  
Vaccine Candidates ◽  
The Status ◽  
Experimental Findings ◽  
Theoretical Issues

This review provides a comparison of the theoretical issues and experimental findings for plasmid DNA and mRNA vaccine technologies. While both have been under development since the 1990s, in recent years, significant excitement has turned to mRNA despite the licensure of several veterinary DNA vaccines. Both have required efforts to increase their potency either via manipulating the plasmid DNA and the mRNA directly or through the addition of adjuvants or immunomodulators as well as delivery systems and formulations. The greater inherent inflammatory nature of the mRNA vaccines is discussed for both its potential immunological utility for vaccines and for the potential toxicity. The status of the clinical trials of mRNA vaccines is described along with a comparison to DNA vaccines, specifically the immunogenicity of both licensed veterinary DNA vaccines and select DNA vaccine candidates in human clinical trials.

Human Clinical Trials of Plasmid DNA Vaccines

2005 ◽  
pp. 25-40 ◽  
Author(s):  
Margaret A. Liu ◽  
Jeffrey B. Ulmer
Keyword(s):  
Clinical Trials ◽  
Plasmid Dna ◽  
Dna Vaccines

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

Vaccine ◽  
2010 ◽  
Vol 28 (13) ◽  
pp. 2565-2572 ◽  
Author(s):  
Larry R. Smith ◽  
Mary K. Wloch ◽  
Ming Ye ◽  
Luane R. Reyes ◽  
Souphaphone Boutsaboualoy ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Influenza A Virus ◽  
Plasmid Dna ◽  
Influenza A ◽  
Dna Vaccines ◽  
Phase 1

Evaluation of biocompatibility and efficiency of plasmid DNA delivery by gene-activated hydrogels in vitro

2019 ◽  
Vol XIV (2) ◽  
Author(s):  
I.Y. Bozo ◽  
A.A. Titova ◽  
M.N. Zhuravleva ◽  
A.I. Bilyalov ◽  
M.O. Mavlikeev ◽  
...  
Keyword(s):  
Plasmid Dna ◽  
Dna Delivery

Modification of Collagen for Biomedical Applications: A Review of Physical and Chemical Methods

2016 ◽  
Vol 20 (17) ◽  
pp. 1797-1812 ◽  
Author(s):  
Xiaoyue Yu ◽  
Cuie Tang ◽  
Shanbai Xiong ◽  
Qijuan Yuan ◽  
Zhipeng Gu ◽  
...  
Keyword(s):  
Biomedical Applications ◽  
Chemical Methods ◽  
Physical And Chemical

Biomedical Applications and Patents on Metallic Nanoparticles

2020 ◽  
Vol 10 ◽  
Author(s):  
Geetanjali Singh ◽  
Pramod Kumar Sharma ◽  
Rishabha Malviya
Keyword(s):  
Metallic Nanoparticles ◽  
Biomedical Applications ◽  
Size Range ◽  
Biomedical Application ◽  
Chemical Reduction ◽  
Chemical Methods ◽  
Future Challenges ◽  
Biological Methods ◽  
Cancer Diagnosis And Therapy ◽  
Physical And Chemical

Aim/Objective: The author writes the manuscript by reviewing the literatures related to the biomedical application of metallic nanoparticles. The term metal nanoparticles are used to describe the nanosized metals with the dimension within the size range of 1-100 nm. Methods: The preparation of metallic nanoparticles and their application is an influential area for research. Among various physical and chemical methods (viz. chemical reduction, thermal decomposition, etc.) for synthesizing silver nanoparticles, biological methods have been suggested as possible eco-friendly alternatives. The synthesis of metallic nanoparticles is having many problems inclusive of solvent toxicity, the formation of hazardous byproducts and consumption of energy. So it is important to design eco-friendly benign procedures for the synthesis of metallic nanoparticles. Results: From the literature survey, we concluded that metallic nanoparticles have applications in the treatment of different diseases. Metallic nanoparticles are having a great advantage in the detection of cancer, diagnosis, and therapy. And it can also have properties such as antifungal, antibacterial, anti-inflammatory, antiviral and anti-angiogenic. Conclusion: In this review, recent upcoming advancement of biomedical application of nanotechnology and their future challenges has been discussed.

scholarly journals Leveraging epigenetics to enhance the efficacy of immunotherapy

2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Jonathan D. Licht ◽  
Richard L. Bennett
Keyword(s):  
Gene Expression ◽  
Clinical Trials ◽  
Antigen Presentation ◽  
Tumor Cells ◽  
Immune Evasion ◽  
Regulatory Elements ◽  
Chromatin Accessibility ◽  
Epigenetic Modifications ◽  
Main Body ◽  
Epigenetic Mechanisms

Abstract Background Epigenetic mechanisms regulate chromatin accessibility patterns that govern interaction of transcription machinery with genes and their cis-regulatory elements. Mutations that affect epigenetic mechanisms are common in cancer. Because epigenetic modifications are reversible many anticancer strategies targeting these mechanisms are currently under development and in clinical trials. Main body Here we review evidence suggesting that epigenetic therapeutics can deactivate immunosuppressive gene expression or reprogram tumor cells to activate antigen presentation mechanisms. In addition, the dysregulation of epigenetic mechanisms commonly observed in cancer may alter the immunogenicity of tumor cells and effectiveness of immunotherapies. Conclusions Therapeutics targeting epigenetic mechanisms may be helpful to counter immune evasion and improve the effectiveness of immunotherapies.

Sign in / Sign up

Export Citation Format

Share Document